Stock Movers: Insulet Surges, Disney Rises, Palantir Dips

Insulet's Strong Performance

• 🚀 Insulet was a top performer in the S&P 500 this week, jumping 20%.
• 💡 The insulin pump maker boosted its full-year revenue guidance and reported better-than-expected first-quarter results.
• 📈 Piper Sandler views the guidance increase positively, seeing it as evidence of strong business momentum.

Disney's Upward Trend

• ✨ Disney shares rose significantly, up 14% for the week.
• 🎯 The company beat second-quarter expectations and raised its full-year outlook, driven by strong performance in theme parks and streaming.
• 📊 Disney's forecast for full-year EPS growth doubled its previous projection, indicating continued strength in its core businesses.

Palantir's Setback

• 📉 Palantir shares experienced a significant drop, finishing the week down 5.6%.
• ⚠️ Despite beating earnings expectations and raising its 2025 revenue forecast, the stock's high valuation and substantial year-to-date gains led to investor caution.
• 📊 The company described demand for its artificial intelligence software as a "ravenous whirlwind."